Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+49 0761 1514 0 Fax:+49 0761 1514 321 Email: zentrale@drfalkpharma.de

  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence & business partners
  • Indications
    • Autoimmune Hepatitis
    • Chronic Constipation
    • Colonoscopy
    • Crohn’s Disease
    • Eosinophilic Esophagitis
    • Hemorrhoidal disease
    • Irritable Bowel Syndrome
    • Microscopic Colitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our Products
  • Partnering
  • Newsroom
  • Falk Foundation
  • Contact us
  • Events
  • Reporting adverse events
  • Falsified medicines regulations
  • Imprint
  • Data Privacy
  • Social media guidelines
Contact:
Phone:
+49 0761 1514 0
Fax:
+49 0761 1514 321
Email:
zentrale[at]drfalkpharma.de
  • Homepage
  • Search

Search results

110 results

  • NEWSROOM
    Strategic Partnership with Allianthera (Suzhou) Biopharmaceuticals
    for Novel AhR Agonist Development for the Treatment of Moderate to Severe Ulcerative Colitis
  • NEWSROOM
    Today is World Liver Day!
    Did you know that our first product back in 1960 was a therapeutic drug for the liver?
  • NEWSROOM
    World EoE Day 2025
    Help to raise awareness on May 22, 2025!
  • NEWSROOM
    EASL 2025
    Join us from 7 – 10 May 2025 at the EASL Congress 2025 in Amsterdam, the Netherlands or online.
  • Why we are
    Why we are Homepage About us Why we are Why we are It always starts with an idea The idea of Dr. Dr. Herbert Falk is "Progress through interaction" in the field of gastroenterology and hepatology.…
  • Supplier Code of Conduct
    Supplier Code of Conduct Homepage About us Corporate Sustainability Supplier Code of Conduct Supplier Code of Conduct Company Policy Preamble Dr. Falk Pharma endeavors to live up to its responsibility…
  • Corporate Sustainability
    Corporate Sustainability Homepage About us Corporate Sustainability Sustainability at Falk As a family-run company that is now in its second generation of family ownership, it is in our nature to…
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma GmbH

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. 

  • Falk Foundation
  • Events
  • Headquarters
  • Reporting adverse events
  • Falsified medicines regulations
  • Social media guidelines
© 2025 Dr. Falk Pharma GmbH
  • Imprint
  • Data Privacy
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are leaving the website of Dr. Falk Pharma.

We are not liable for the accuracy of any content published on third party websites - such as the one you are about to be forwarded to.